Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Quagliata

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2014
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21Marion Cornu, Wolfgang Oppliger, Verena Albert, et al.
Hepatology (Baltimore, Md.)|March 16, 2017
Down-regulation of hepatocyte nuclear factor-4α and defective zonation in livers expressing mutant Z α1-antitrypsinPasquale Piccolo, Patrizia Annunziata, Leandro R Soria, et al.
Frontiers in Genetics|February 20, 2018
Genomic Analysis Revealed New Oncogenic Signatures in <i>TP53</i>-Mutant Hepatocellular CarcinomaVenkatesh Kancherla, Samir Abdullazade, Matthias S Matter, et al.
Scientific Reports|March 16, 2019
Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular CarcinomaCarolin Lackner, Luca Quagliata, William Cross, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patientEva Dazert, Marco Colombi, Tujana Boldanova, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinomaZuzanna Makowska, Tujana Boldanova, David Adametz, et al.
Molecular Carcinogenesis|May 4, 2017
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapyCristina Quintavalle, Katharina Burmeister, Salvatore Piscuoglio, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2020
Robust assessment of tumor mutational burden in cytological specimens from lung cancer patientsIlaria Alborelli, Ivana Bratic Hench, Obinna Chijioke, et al.
Journal of Gastroenterology and Hepatology|January 5, 2017
Liver damage and senescence increases in patients developing hepatocellular carcinomaSilvia Rey, Cristina Quintavalle, Katharina Burmeister, et al.
Hepatology (Baltimore, Md.)|March 19, 2015
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesisPatrizia Zavattari, Andrea Perra, Silvia Menegon, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2014
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21Marion Cornu, Wolfgang Oppliger, Verena Albert, et al.
Hepatology (Baltimore, Md.)|March 16, 2017
Down-regulation of hepatocyte nuclear factor-4α and defective zonation in livers expressing mutant Z α1-antitrypsinPasquale Piccolo, Patrizia Annunziata, Leandro R Soria, et al.
Frontiers in Genetics|February 20, 2018
Genomic Analysis Revealed New Oncogenic Signatures in <i>TP53</i>-Mutant Hepatocellular CarcinomaVenkatesh Kancherla, Samir Abdullazade, Matthias S Matter, et al.
Scientific Reports|March 16, 2019
Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular CarcinomaCarolin Lackner, Luca Quagliata, William Cross, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patientEva Dazert, Marco Colombi, Tujana Boldanova, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinomaZuzanna Makowska, Tujana Boldanova, David Adametz, et al.
Molecular Carcinogenesis|May 4, 2017
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapyCristina Quintavalle, Katharina Burmeister, Salvatore Piscuoglio, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2020
Robust assessment of tumor mutational burden in cytological specimens from lung cancer patientsIlaria Alborelli, Ivana Bratic Hench, Obinna Chijioke, et al.
Journal of Gastroenterology and Hepatology|January 5, 2017
Liver damage and senescence increases in patients developing hepatocellular carcinomaSilvia Rey, Cristina Quintavalle, Katharina Burmeister, et al.
Hepatology (Baltimore, Md.)|March 19, 2015
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesisPatrizia Zavattari, Andrea Perra, Silvia Menegon, et al.
Pageof 7